Baxter International Inc. Baxter International Inc.

Baxter International Inc.

BAX

อันดับในหุ้น #1669
Baxter International Inc., operating globally via its subsidiaries, is a... Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.
ราคาหุ้น
$24.77
มูลค่าตลาด
$12.80B
การเปลี่ยนแปลง (1 วัน)
1.18%
การเปลี่ยนแปลง (1 ปี)
8.86%
ประเทศ
US
ซื้อขาย Baxter International Inc. (BAX)

หมวดหมู่

Healthcare
ประวัติราคาหุ้นของ Baxter International Inc. (BAX)
ราคาปิดสูงสุด: $24.50 เมื่อ 2026-10-01

ราคาปิดต่ำสุด: $1.24 เมื่อ 1968-01-01
ประวัติราคาหุ้นของ Baxter International Inc. ตั้งแต่ 1968 ถึง 2026
ผลการดำเนินงานราคาหุ้นรายปี
ปี ประสิทธิภาพ
2026 (TTM) 9.18%
2025 -37.87%
2024 -19.17%
2023 -26.58%
2022 -37.82%
2021 4.71%
2020 -5.13%
2019 27.28%
2018 0.97%
2017 45.75%
2016 18.35%
2015 -6.06%
2014 8.56%
2013 2.52%
2012 32.60%
2011 -1.46%
2010 -12.59%
2009 10.28%
2008 -11.23%
2007 29.05%
2006 18.88%
2005 16.23%
2004 11.18%
2003 0.52%
2002 -42.86%
2001 21.11%
2000 42.69%
1999 -1.25%
1998 26.88%
1997 21.07%
1996 -0.65%
1995 55.34%
1994 15.17%
1993 -30.49%
1992 -12.08%
1991 34.83%
1990 14.02%
1989 40.78%
1988 -20.99%
1987 12.10%
1986 28.38%
1985 21.77%
1984 -43.48%
1983 -7.24%
1982 48.76%
1981 32.71%
1980 2.30%
1979 14.95%
1978 13.16%
1977 -3.52%
1976 -5.71%
1975 21.22%
1974 -27.20%
1973 -15.90%
1972 49.07%
1971 44.68%
1970 -15.36%
1969 43.27%
1968 0.00%
ราคาหุ้นของบริษัทที่คล้ายกันหรือคู่แข่ง
บริษัท ราคาหุ้น การเปลี่ยนแปลง 1ปี% ประเทศ
$431.34 -6.79%
US
$195.69 -46.72%
FR
$175.05 16.02%
JP
$194.26 30.72%
US
$67.71 -10.49%
CH